Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
CancerSurgeryFatigue
Interventions
DRUG

PG2

Powder for Injection, 500 mg PG2/500 ml normal saline

DRUG

Placebo

500 mL normal saline

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

Sponsors
All Listed Sponsors
lead

PhytoHealth Corporation

INDUSTRY